The physiologic importance of FGF21 is evident from studies showing that systemic administration of FGF21 reduces serum and liver triacylglycerol (TAG) concentrations, body weight and obesity in obese mice [4-6]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.